New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease.
- Published in:
- Journal of Parkinson's Disease, 2013, v. 3, n. 3, p. 301, doi. 10.3233/JPD-130207
- By:
- Publication type:
- Article
Works by Benadiba, Marcel
Results: 7
1
2
New molecular targets for PET and SPECT imaging in neurodegenerative diseases.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2012, v. 34, n. S2, p. S125, doi. 10.1016/j.rbp.2012.07.002
- By:
- Publication type:
- Article
3
<sup>11</sup>C- and <sup>18</sup>F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography.
- Published in:
- ChemMedChem, 2016, v. 11, n. 1, p. 108, doi. 10.1002/cmdc.201500420
- By:
- Publication type:
- Article
4
Gamma-linolenic acid alters Ku80, E2F1, and bax expression and induces micronucleus formation in C6 glioma cells in vitro.
- Published in:
- IUBMB Life, 2009, v. 61, n. 3, p. 244, doi. 10.1002/iub.154
- By:
- Publication type:
- Article
5
Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression.
- Published in:
- Lipids in Health & Disease, 2009, v. 8, p. 1, doi. 10.1186/1476-511X-8-8
- By:
- Publication type:
- Article
6
The novel ruthenium- γ-linolenic complex [Ru<sub>2</sub>(aGLA)<sub>4</sub>Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
- Published in:
- Cell Biochemistry & Function, 2010, v. 28, n. 1, p. 15, doi. 10.1002/cbf.1626
- By:
- Publication type:
- Article
7
Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [RuCl(Ibp)], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2014, v. 19, n. 6, p. 1025, doi. 10.1007/s00775-014-1143-4
- By:
- Publication type:
- Article